Economic support to patients in HIV and TB grants in rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria

Show simple item record

dc.date.accessioned 2014-02-06 en
dc.date.accessioned 2022-08-17T17:21:27Z
dc.date.available 2022-08-17T17:21:27Z
dc.date.issued 2015-08-25 en
dc.identifier.uri http://hdl.handle.net/20.500.11910/2681
dc.description.abstract People with TB and/or HIV frequently experience severe economic barriers to health care, including out-of-pocket expenses related to diagnosis and treatment, as well as indirect costs due to loss of income. These barriers can both aggravate economic hardship and prevent or delay diagnosis, treatment and successful outcome, leading to increased transmission, morbidity and mortality. WHO, UNAIDS and the ILO argue that economic support of various kinds is essential to enable vulnerable people to protect themselves from infection, avoid delayed diagnosis and treatment, overcome barriers to adherence, and avert destitution. This paper analyses successful country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria that include economic support in Rounds 7 and 10; 36 and 20 HIV and TB grants in Round 7 and 32 and 26, respectively, in Round 10. Of these, up to 84 percent included direct or indirect economic support for beneficiaries, although the amount constituted a very small proportion of the total grant. In TB grants, the objectives of economic support were generally clearly stated, and focused on mechanisms to improve treatment uptake and adherence, and the case was most clearly made for MDR-TB patients. In HIV grants, the objectives were much broader in scope, including mitigation of adverse economic and social effects of HIV and its treatment on both patients and families. The analysis shows that economic support is on the radar for countries developing Global Fund proposals, and a wide range of economic support activities are in place. In order to move forward in this area, the wealth of country experience that exists needs to be collated, assessed and disseminated. In addition to trials, operational research and programme evaluations, more precise guidance to countries is needed to inform evidence-based decision about activities that are cost-effective, affordable and feasible. en
dc.format.medium Print en
dc.subject HIV/AIDS en
dc.subject TUBERCULOSIS en
dc.subject SOCIAL GRANTS en
dc.subject FINANCIAL SUPPORT en
dc.subject GLOBAL FUND TO FIGHT AIDS en
dc.title Economic support to patients in HIV and TB grants in rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria en
dc.type Journal Article en
dc.description.version Y en
dc.ProjectNumber N/A en
dc.Volume 9(1) en
dc.BudgetYear 2013/14 en
dc.ResearchGroup HIV/AIDS, STIs and TB en
dc.ResearchGroup Human and Social Development en
dc.SourceTitle PLoS One en
dc.ArchiveNumber 8034 en
dc.URL http://ktree.hsrc.ac.za/doc_read_all.php?docid=13673 en
dc.PageNumber Online en
dc.outputnumber 6680 en
dc.bibliographictitle Richter, L.M., Lonnroth, K., Desmond, C., Jackson, R., Jaramillo, E. & Weil, D. (2014) Economic support to patients in HIV and TB grants in rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria. PLoS One. 9(1):Online. http://hdl.handle.net/20.500.11910/2681 en
dc.publicationyear 2014 en
dc.contributor.author1 Richter, L.M. en
dc.contributor.author2 Lonnroth, K. en
dc.contributor.author3 Desmond, C. en
dc.contributor.author4 Jackson, R. en
dc.contributor.author5 Jaramillo, E. en
dc.contributor.author6 Weil, D. en


Files in this item

This item appears in the following Collection(s)

Show simple item record